Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03568539
Title IBI308 in Subjects With Advanced/Metastatic Solid Malignancies
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Innovent Biologics (Suzhou) Co. Ltd.
Indications

urinary bladder cancer

prostate cancer

colorectal cancer

melanoma

stomach cancer

endometrial cancer

lung non-small cell carcinoma

lung small cell carcinoma

Therapies

Sintilimab

Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
UC Irvine Medical Center Orange California 92868 United States Details
Northside Hospital, Inc Atlanta Georgia 30342 United States Details
Henry Ford Medical Center Detroit Michigan 48202 United States Details
Comprehensive Cancer Centers of Nevada Las Vegas Nevada 89169 United States Details
Icahn School of Medicine at Mount Sinai New York New York 10029 United States Details
University of Oklahoma Health Sciences Center Oklahoma City Oklahoma 73104 United States Details
Mary Crowley Cancer Research Dallas Texas 75230 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field